|
Highlights
- First blood and saliva tests in North America to detect
INVASIVE Candida
- Has been correlated with Gas Chromatography and Tissues
Tests
- FDA Approved
- Requires Blood Draw – Fasting is Not Required
- Lab Processing time: 2 - 4 days
Invasive Candidiasis is a serious condition that affects thousands
of patients. Candida is yeast that normally inhabits a healthy
colon in small numbers. However, in many cases, the yeast
becomes so prolific that it escapes the confines of the intestinal
tract and causes havoc throughout the rest of the body creating
a condition termed invasive Candidiasis. These microorganisms
produce gas and toxins that irritate and can damage tissues,
glands, or organs and severely compromise the immune system.
Various autoimmune conditions are linked to Candidiasis, where
cross reactivity (molecular mimicry) with human tissue and
Candida organisms has occurred.
Other tests may not be reliable in differentiating between
Invasive and Non-Invasive Candida. However, with BioHealth’s
new D-Arabinitol test health care practitioners now have the
tool they need for accurate diagnosis, treatment, and monitoring
the efficacy of treatment protocols.
The five-carbon sugar alcohol D-Arabinitol (DA) is a metabolite
of most pathogenic Candida species in vivo and in vitro including:
Candida albicans, Candida tropicalis, Candida parapsilosis,
Candida pseudotropicalis, Candida kefyr, Candida lusitaniae
and Candida guilliermondii. (Please note that strains of Candida
glabrata, Candida krusei and Candida neoformans do not produce
D-Arabinitol in vitro). The D-Arabinitol level is determined
on serum or saliva by gas chromatography or enzymatic analysis.
Positive DA results have been obtained several days to weeks
before positive Candida blood cultures and the normalization
of DA levels has been correlated with the therapeutic response
in both humans and animals. By looking at DA, the direct metabolite
of pathogenic Candida species listed above, it is possible
to assess whether a person has invasive Candidiasis.
The D-Arabinitol test differentiates between Invasive and
Non-Invasive Candida. Results may be interpreted as follows:
SERUM
1.0 - 5.0 umol/l No evidence of invasive Candida.
5.1 – 9.0 umol/l Equivocal – Candida problem but
not Invasive
> 9.0 umol/l Presumptive Evidence of Invasive Candida
SALIVA
3.0 - 9.0 umol/l No evidence of invasive Candida.
9.0 -– 15.0 umol/l Equivocal – Candida problem
but not Invasive
> 15.0 umol/l Presumptive Evidence of Invasive Candida
Common Symptoms Associated with Candidiasis
- inability to concentrate poor memory fatigue
- PMS weight gain bloating
- flatulence constipation diarrhea
- hormonal problems vaginal infection menstrual difficulties
- impotence infertility prostatitis
- rectal itch carbohydrate cravings urinary tract
- infection/inflammation allergies: to foods and/or airborne
chemicals, especially cigarette smoke
|
